Back to Trials
NCT07210437NARecruiting

Longitudinal Autonomic Characterization as a Predictor for Secondary Medical Complications Post-SCI

Mayo Clinic

Start Date

1/31/2026

Completion Date

6/1/2028

Summary

The purpose of this research is to learn about how the body is able to balance changes in blood pressure, how that changes over time, and how these changes impact a participant's risk of developing medical problems.

Eligibility Criteria

Age Range: 18 years to 75 years

Inclusion criteria * 18-75 years old * Spinal cord injury with neurological level of injury from C6-T12 * ASIA Impairment Scale A-D. * Either acute SCI \<3 months prior (n=10) or chronic SCI (\>1 year since injury, n=8). Exclusion criteria * Symptoms of cardiovascular (including, but not limited to: hypertension, stroke, chest pain, etc.), respiratory, peripheral neurological or autonomic disease (particularly diabetes mellitus requiring treatment); * Women who are pregnant or lactating * Taking or being administered a medication known to potentially have adverse interactions with phenylephrine * In the judgement of the principal investigator, any illness or condition that will interfere with the patient's ability to comply with the protocol, compromise patient safety, or interfere with the interpretation of the study results.

Interventions

DIAGNOSTIC_TEST

Tests of sympathetic inhibition

DIAGNOSTIC_TEST

Tests of above level sympathetic activation

DIAGNOSTIC_TEST

Testing of below level sympathetic activation

Interested in This Trial?

Contact the trial locations directly using the information below to learn more about enrollment.

Expressing interest lets you review the study and consent before we connect you with the research site.

Conditions

Spinal Cord Injuries

Locations

Mayo Clinic

Rochester, Minnesota 55905

United States